Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API

Protease and Inhibitor Mechanisms

22 та иш

  1. Activation and Decay Curves of Thyroxin

    Walter M. Boothby, E.J. Baldes, Charles Sheard +1

    МақолаThyroid Disorders and TreatmentsMayo Clinic Proceedings19260 иқтибос
    ABI

  2. Rapid purification of tissue inhibitor of metalloproteinases from human plasma and identification as a γ-serum protein

    Tim E. Cawston, D N Noble, Gillian Murphy +3

    МақолаProtease and Inhibitor MechanismsBiochemical Journal19860 иқтибос
    ABI

  3. Rational Design of Complex Formation between Plasminogen Activator Inhibitor-1 and Its Target Proteinases

    Kathleen Aertgeerts, C. J. De Ranter, Nuala A. Booth +1

    МақолаProtease and Inhibitor MechanismsJournal of Structural Biology19970 иқтибос
    ABI

  4. 6β-[(E)-4-Methylsenecioyloxy]-furanoeremophil-1(10)-en-9-one (6β-(3-Methyl-2trans-pentenoyloxy)-9-oxoeuryopsin)

    Shakhnoza S. Azimova, Ashraf I. Saidkhodzhaev

    БобMarine Sponges and Natural Products20120 иқтибос
    ABI

  5. 6β-Isovaleroyloxy-furanoeremophil-1(10)-en-9-one (6β-Isovaleryloxy-9-oxoeuryopsin)

    Shakhnoza S. Azimova, Ashraf I. Saidkhodzhaev

    БобProtease and Inhibitor Mechanisms20120 иқтибос
    ABI

  6. Relationship between the Levels of MMP-9, TIMP-1, and Zinc in Biological Samples of Patients with Carotid Atherosclerosis

    Zakhro Usmanova, Tashkent, Uzbekistan

    МақолаProtease and Inhibitor MechanismsInternational Journal of Biomedicine20150 иқтибос
    ABI

  7. LBPS 02-51 ROLE OF THE SYSTEM METALLOPROTEINASE AND THEIR INHIBITORS AT A HEART FAILURE

    Shukhrat Ziyadullaev, Gavhar Dushanova, Gulchehra Ahmedova

    МақолаGDF15 and Related BiomarkersJournal of Hypertension20160 иқтибос
    ABI

  8. Matrix metalloproteinase -28 alters cellular energetics in macrophages, influencing polarization and activation

    Dorota Tokmina‐Roszyk, Lillian Onwuha‐Ekpete, Mohammed Y. Refai +3

    МақолаProtease and Inhibitor MechanismsThe Journal of Immunology20190 иқтибос
    ABI

  9. Developmentally regulated GTP-binding protein 2 levels in prostate cancer cell lines impact docetaxel-induced apoptosis

    Seong Cheol Kim, Won Hyeok Lee, Song Hee Kim +6

    МақолаCancer Research and TreatmentsInvestigative and Clinical Urology20210 иқтибос
    ABI

  10. The Effect of Ecdystene on the Activity of Matrix Metalloproteinases in Experimental Alloxan Diabetes in Rats

    D. Tursunov, Rixsi A. Sabirova, М. У. Кульманова +5

    МақолаProtease and Inhibitor MechanismsBioNanoScience20210 иқтибос
    ABI

  11. UMURTQALARARO DISK CHURRALARIDA TOʻQIMALI METALLOPROTEINAZA (MMP-1, MMP-8, MMP-9) VA UNING INGIBITORLARI (MPTI-1) DARAJASIGA PAPAYA PREPARATLARINING TAʼSIRI

    Zufar Adambayev, Nilufar Soliyeva

    МақолаProtease and Inhibitor MechanismsMedicineProblems uz-Topical Issues of Medical Sciences20240 иқтибос
    ABI

  12. Structural Optimization of Fibroblast Activation Protein Inhibitors Through Zwitterionic and PEG Modification Strategy: Impact on Pharmacokinetics and Tumor Imaging

    Hongmei Yuan, Haiyang Li, Tongtong Wu +8

    МақолаPeptidase Inhibition and AnalysisMolecular Pharmaceutics20250 иқтибос
    ABI

  13. Development and Evaluation of [<sup>68</sup>Ga]Ga-DOTA-BT1718: A Novel Imaging Agent Targeting MT1-MMP for Malignant Tumor Diagnosis

    Jing Yang, Yanggang Liu, Shijie Tang +7

    МақолаPeptidase Inhibition and AnalysisJournal of Medicinal Chemistry20250 иқтибос
    ABI

  14. Revolutionizing Solid Tumor Surgery with Fibroblast Activation Protein (FAP)-Targeted Imaging Probes for a Fluorescence-Guided Surgery of Pancreatic Cancer

    Hanyue Ma, Lysanne D. A. N. de Muynck, Ruben D. Houvast +7

    МақолаPeptidase Inhibition and AnalysisBioconjugate Chemistry20250 иқтибос
    ABI

  15. Role of the plasma level of plasminogen activator inhibitor type-1 (PAI-1) and genetic polymorphism of &lt;i&gt;PAI-1&lt;/i&gt; gene in patients with ischemic heart disease in Uzbek population

    Наргиза Абдумухтаровна Кадирова, Н Нуриллаева, Victoria B. Petrova +2

    МақолаProtease and Inhibitor MechanismsScience and Innovations in Medicine20250 иқтибос
    ABI

  16. The importance of MMP9 biomarker in the development of acute cerebral ischemia

    Elyorbek Tashkenov, G. Rakhimbaeva Sattarovna

    МақолаProtease and Inhibitor MechanismsJournal of the Neurological Sciences20250 иқтибос
    ABI

  17. Extracellular vesicles in cardiovascular disease: Biomarkers, therapeutic applications, and drug delivery strategies

    Qamar Abuhassan, Ali Salajegheh, Faris Anad Muhammad +10

    МақолаExtracellular vesicles in diseaseClinica Chimica Acta20260 иқтибос
    ABI

  18. ABSTRACT NUMBER: ESOC2026A2162 PLASMA MMP-9 AS A PROGNOSTIC BIOMARKER IN ACUTE HEMORRHAGIC STROKE

    Sardor Musayev, Gulnora Rakhimbaeva, Y. Musaeva +1

    МақолаProtease and Inhibitor MechanismsEuropean Stroke Journal20260 иқтибос
    ABI

  19. ABSTRACT NUMBER: ESOC2026A2144 MATRIX METALLOPROTEINASE-9 AS A PROGNOSTIC BIOMARKER IN ACUTE INTRACEREBRAL HEMORRHAGE

    Sardor Musayev, Gulnora Rakhimbaeva, Y. Musaeva +1

    МақолаIntracerebral and Subarachnoid Hemorrhage ResearchEuropean Stroke Journal20260 иқтибос
    ABI

  20. THE DIFFERENCE BETWEEN THROMBOSIS AND ATHEROSCLEROSIS: BIOCHEMICAL DISSECTION OF TWO PATHOPHYSIOLOGICAL CONTINUUMS

    Nasibaxon Afzalxujaevna Abdukadirova

    МақолаBlood properties and coagulationZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  21. THE DIFFERENCE BETWEEN THROMBOSIS AND ATHEROSCLEROSIS: BIOCHEMICAL DISSECTION OF TWO PATHOPHYSIOLOGICAL CONTINUUMS

    Nasibaxon Afzalxujaevna Abdukadirova

    МақолаBlood properties and coagulationZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  22. Harnessing extracellular vesicles for gastric cancer management: Biomarker discovery and therapeutic strategies

    Ghaleb Oriquat, Ahmed Faisal Mutee, Aziz Kubaev +4

    МақолаExtracellular vesicles in diseaseClinica Chimica Acta20260 иқтибос
    ABI